Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Frame

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
A Digital Protein Microarray for COVID-19 Cytokine Storm MonitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Lab on a Chip|November 19, 2020
A digital protein microarray for COVID-19 cytokine storm monitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomesLawrence Chang, David Frame, Thomas Braun, et al.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.
Journal of Clinical Immunology|August 17, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK InhibitionThomas F Michniacki, Kelly Walkovich, Lauren DeMeyer, et al.
Chest|April 12, 2022
Defibrotide Therapy for SARS-CoV-2 ARDSDavid Frame, Gianni B Scappaticci, Thomas M Braun, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2020
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
A Digital Protein Microarray for COVID-19 Cytokine Storm MonitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Lab on a Chip|November 19, 2020
A digital protein microarray for COVID-19 cytokine storm monitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomesLawrence Chang, David Frame, Thomas Braun, et al.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.
Journal of Clinical Immunology|August 17, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK InhibitionThomas F Michniacki, Kelly Walkovich, Lauren DeMeyer, et al.
Chest|April 12, 2022
Defibrotide Therapy for SARS-CoV-2 ARDSDavid Frame, Gianni B Scappaticci, Thomas M Braun, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2020
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.
Pageof 4